BACTERIAL, ENDOTOXIN - MOLECULAR RELATIONSHIPS OF STRUCTURE TO ACTIVITY AND FUNCTION

被引:1314
作者
RIETSCHEL, ET [1 ]
KIRIKAE, T [1 ]
SCHADE, FU [1 ]
MAMAT, U [1 ]
SCHMIDT, G [1 ]
LOPPNOW, H [1 ]
ULMER, AJ [1 ]
ZAHRINGER, U [1 ]
SEYDEL, U [1 ]
DIPADOVA, F [1 ]
SCHREIER, M [1 ]
BRADE, H [1 ]
机构
[1] SANDOZ,PRECLIN RES,CH-4002 BASEL,SWITZERLAND
关键词
LIPOPOLYSACCHARIDE; LIPID A; TUMOR NECROSIS FACTOR; INTERLEUKIN; 1; ANTI-LPS ANTIBODIES; LPS ANTAGONISTS; MONOCYTES; SPHINGOGLYCOLIPID;
D O I
10.1096/fasebj.8.2.8119492
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Endotoxins of Gram-negative microbes fulfill as components of the outer membrane a vital function for bacterial viability and, if set free, induce in mammalians potent pathophysiological effects. Chemically, they are lipopolysaccharides (LPS) consisting of an O-specific chain, a core oligosaccharide, and a lipid component, termed lipid A. The latter determines the endotoxic activities and, together with the core constituent Kdo, essential functions for bacteria. The primary structure of lipid A of various bacterial origin has been elucidated and lipid A of Escherichia coli has been chemically synthesized. The biological analysis of synthetic lipid A partial structures proved that the expression of endotoxic activity depends on a unique primary structure and a peculiar endotoxic conformation. The biological lipid A effects are mediated by macrophage-derived bioactive peptides such as tumor necrosis factor alpha (TNF). Macrophages possess LPS receptors, and the lipid A regions involved in specific binding and cell activation have been characterized. Synthetic lipid A partial structures compete the specific binding of LPS or lipid A and antagonistically inhibit the production of LPS-induced TNF. LPS toxicity, in general, and the ability of LPS to induce TNF are also suppressed by a recently developed monoclonal antibody (IgG2a), which is directed against an epitope located in the core oligosaccharide. At present we determine molecular and submolecular details of the specificity of the interaction of lipid A with responsive host cells with the ultimate aim to provide pharmacological or immunological therapeutics that reduce or abolish the fatal inflammatory consequences of endotoxicosis.
引用
收藏
页码:217 / 225
页数:9
相关论文
共 67 条
[1]   LIPOPOLYSACCHARIDE, LIPID-A, AND LIPOSOMES CONTAINING LIPID-A AS IMMUNOLOGICAL ADJUVANTS [J].
ALVING, CR .
IMMUNOBIOLOGY, 1993, 187 (3-5) :430-446
[2]  
ARDITI M, 1993, IN PRESS INFECT IMMU
[3]   IMMUNOTHERAPY OF ENDOTOXEMIA AND SEPTICEMIA [J].
BAUMGARTNER, JD ;
GLAUSER, MP .
IMMUNOBIOLOGY, 1993, 187 (3-5) :464-477
[4]  
BELUNIS CJ, 1992, J BIOL CHEM, V267, P18702
[5]  
BRADE H, 1988, ZBL BAKT-INT J MED M, V268, P151
[6]   CHEMICAL AND SEROLOGICAL INVESTIGATIONS ON THE GENUS-SPECIFIC LIPOPOLYSACCHARIDE EPITOPE OF CHLAMYDIA [J].
BRADE, H ;
BRADE, L ;
NANO, FE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (08) :2508-2512
[7]  
CLEMENTZ T, 1991, J BIOL CHEM, V266, P9687
[8]  
COLWELL DE, 1984, J IMMUNOL, V133, P950
[9]   A BROADLY CROSS-PROTECTIVE MONOCLONAL-ANTIBODY BINDING TO ESCHERICHIA-COLI AND SALMONELLA LIPOPOLYSACCHARIDES [J].
DIPADOVA, FE ;
BRADE, H ;
BARCLAY, GR ;
POXTON, IR ;
LIEHL, E ;
SCHUETZE, E ;
KOCHER, HP ;
RAMSAY, G ;
SCHREIER, MH ;
MCCLELLAND, DBL ;
RIETSCHEL, ET .
INFECTION AND IMMUNITY, 1993, 61 (09) :3863-3872
[10]  
DIPADOVA FE, 1993, ENDOTOXIN RES SERIES, V2, P325